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Osteoporosis results in signiﬁcant morbidity and medical
costs while eﬀective treatment options are also evolving.
Bisphosphonates are considered standard antiosteoporotic
medication.Otherantiresorptivetreatmentoptionsofosteo-
porosis include selective oestrogen receptor modulators,
hormone therapy, calcitonin, and denosumab. In addition,
strontium ranelate of dual mechanism (anabolic and antire-
sorptive) is available for primary treatment of osteoporosis
and anabolic drugs as parathyroid hormone for more severe
bone fragility. The long-term bone protective, and possible
adverse, eﬀect of the osteoporosis medications needs exclu-
siveresearch.Asanexample,ithasbeenspeculatedthatlong-
term use of BPs could result in pathologic fractures.
Thefocusofthisspecialissueisonnewissuesintheman-
agement of osteoporosis.
The ﬁrst paper of this special issue, “Mikkeli Osteoporosis
index identiﬁes fracture risk factors and osteoporosis and
intervention thresholds parallel with FRAX” deals with iden-
tiﬁcation of osteoporosis and fragility fractures in post-
menopausalwomenbasedonindividual riskfactorproﬁle.It
introduces and validates the Mikkeli Osteoporosis Index
(MOI) and compares its performance to WHO FRAX tool
in separate Finnish cohorts of postmenopausal women. The
performance of MOI was found to be comparable to that of
World Health Organization (WHO) FRAX-tool in identiﬁ-
cation of intervention thresholds.
The second paper, “The eﬀects of parathyroid hormone
applied at diﬀerent regimes on the trochanteric region of the
femur in ovariectomized rat model of osteoporosis” addresses
the eﬀects of parathyroid hormone on trochanteric bone
in rat model. The eﬀects of PTH on biomechanical and
histomorphometric parameters of the trochanteric region
are compared between two application frequencies in
ovariectomised rats. The increased bone formation rate was
observed under PTH treatment mainly at the endosteal side.
The third paper of the special issue, “The facial skeleton
in patients with osteoporosis: a ﬁeld for disease signs and
treatment complications” focuses on the changes of the
facial skeleton in osteoporosis. The paper includes review
of the eﬀects of osteoporosis on inner ear and oral health
as well as eﬀects of osteoporosis treatment modalities on
facial skeleton. Facial skeleton was concluded to experience
several noteworthy changes due to osteoporosis and associ-
ated treatments.
The fourth paper of the special issue, “Bisphosphonates
and atypical fractures of femur” deals with severe compli-
cation of bisphosphonate therapy. It includes review of the
current knowledge on the eﬀects of long-term bisphospho-
nate therapy on atypical fractures of the femur. The paper
includes description of the atypical fractures from the view
of pathophysiology, epidemiology, and case report series.
The last paper, “Similarities in acquired factors related to
postmenopausal osteoporosis and sarcopenia” reviews the cur-
rent knowledge of the interaction between sarcopenia and
osteoporosis in postmenopausal women. The paper de-
scribes the up-to-date diagnostic criteria for the two syn-
dromes and includes detailed review of the common risk
and preventive factors. The paper proposes a close harmony
between decline in bone and muscle health among the
elderly.
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